These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11366499)

  • 1. Advances in CMV management: fomivirsen (Vitravene) approved.
    Proj Inf Perspect; 1998 Dec; (26):7. PubMed ID: 11366499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fomivirsen approved for CMV retinitis.
    Roehr B
    J Int Assoc Physicians AIDS Care; 1998 Oct; 4(10):14-6. PubMed ID: 11365956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New CMV retinitis drug approved.
    Body Posit; 1998 Oct; 11(10):10. PubMed ID: 11365907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fomivirsen approved for CMV retinitis: first antisense drug.
    AIDS Treat News; 1998 Sep; (302):7. PubMed ID: 11365764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First eye implant approved.
    AIDS Alert; 1996 May; 11(5):59. PubMed ID: 11363254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two advances ease burden of CMV treatment.
    Vazquez E
    Posit Aware; 1996; 7(3):8. PubMed ID: 11363430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saving sight.
    Vazquez E
    Posit Aware; 1997; 8(6):22-3. PubMed ID: 11364857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technology evaluation: fomivirsen, Isis Pharmaceuticals Inc/CIBA vision.
    Orr RM
    Curr Opin Mol Ther; 2001 Jun; 3(3):288-94. PubMed ID: 11497353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CMV treatment.
    Treat Rev; 1995; (no 19):4. PubMed ID: 11362756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New CMV drug won't replace other therapies.
    AIDS Alert; 1998 Nov; 13(11):124-6. PubMed ID: 11365968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA approves oral ganciclovir as first drug to prevent CMV disease. Food and Drug Administration.
    Baker R
    BETA; 1995 Dec; ():8. PubMed ID: 11363015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cidofovir recommended for approval for CMV retinitis.
    James JS
    AIDS Treat News; 1996 Apr; (no 244):6-7. PubMed ID: 11363308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral ganciclovir.
    Schouten JT
    STEP Perspect; 1995; 7(3):1, 11. PubMed ID: 11362979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fomivirsen.
    Highleyman L
    BETA; 1998 Apr; ():29, 31. PubMed ID: 11365261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isis presents data on safety and effectiveness of antisense CMV retinitis compound.
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):50. PubMed ID: 11363533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganciclovir implants: one year later.
    Cadman J
    GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ganciclovir implants (Vitrasert).
    Treat Rev; 1996 Apr; (no 21):10. PubMed ID: 11363393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foscavir receives new indication.
    AIDS Alert; 1997 Jun; 12(6):71. PubMed ID: 11364364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral ganciclovir effective for CMV.
    Grodeck B
    Posit Aware; 1995; ():9. PubMed ID: 11362580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral ganciclovir: role in maintenance therapy for CMV retinitis in AIDS patients.
    Owens RC; Ross JW
    Conn Med; 1996 Nov; 60(11):663-5. PubMed ID: 8979433
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.